StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.84−0.03 (-3.91%)

Close on Nov 17, 2026Market cap $13.38MP/E –Yield –

Allarity Therapeutics cash

Cash and short-term investments held at the end of each period.

Allarity Therapeutics's cash was $16.98M at Jun 30, 2026. For fiscal 2025 it was $14.69M, down 24.8% from the year before. The highest annual figure on record is $19.56M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$14.69M-24.8%
FY2024Dec 31, 2024$19.53M+11666.9%
FY2023Dec 31, 2023$166.00K-91.8%
FY2022Dec 31, 2022$2.03M-89.6%
FY2021Dec 31, 2021$19.56M+6462.1%
FY2020Dec 31, 2020$298.00K-80.4%
FY2019Dec 31, 2019$1.52M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$16.98M-4.6%
Q1 FY2026Mar 31, 2026$19.81M-21.4%
Q4 FY2025Dec 31, 2025$14.69M-24.8%
Q3 FY2025Sep 30, 2025$16.90M-8.7%
Q2 FY2025Jun 30, 2025$17.80M-7.4%
Q1 FY2025Mar 31, 2025$25.20M+7977.2%
Q4 FY2024Dec 31, 2024$19.53M+11666.9%
Q3 FY2024Sep 30, 2024$18.50M+1222.4%
Q2 FY2024Jun 30, 2024$19.23M+4479.3%
Q1 FY2024Mar 31, 2024$312.00K-84.6%
Q4 FY2023Dec 31, 2023$166.00K-95.8%
Q3 FY2023Sep 30, 2023$1.40M-81.8%
Q2 FY2023Jun 30, 2023$420.00K-97.1%
Q4 FY2022Dec 31, 2022$2.03M-89.6%
Q3 FY2022Sep 30, 2022$3.95M-29.3%
Q2 FY2022Jun 30, 2022$7.68M+16.4%
Q1 FY2022Mar 31, 2022$14.54M+13751.4%
Q4 FY2021Dec 31, 2021$19.56M+6462.1%
Q3 FY2021Sep 30, 2021$5.58M+18513.3%
Q2 FY2021Jun 30, 2021$6.60M+332.9%
Q1 FY2021Mar 31, 2021$105.00K–
Q4 FY2020Dec 31, 2020$298.00K–
Q3 FY2020Sep 30, 2020$30.00K–
Q4 FY2019Dec 31, 2019$1.52M–

More Allarity Therapeutics figures

See a number that looks wrong?